bmy 45778 has been researched along with mre 269 in 1 studies
Studies (bmy 45778) | Trials (bmy 45778) | Recent Studies (post-2010) (bmy 45778) | Studies (mre 269) | Trials (mre 269) | Recent Studies (post-2010) (mre 269) |
---|---|---|---|---|---|
16 | 0 | 4 | 33 | 10 | 29 |
Protein | Taxonomy | bmy 45778 (IC50) | mre 269 (IC50) |
---|---|---|---|
Prostacyclin receptor | Homo sapiens (human) | 0.288 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnaud, C; Blaise, S; Boutonnat, J; Cracowski, JL; Godin-Ribuot, D; Kotzki, S; Roustit, M | 1 |
1 other study(ies) available for bmy 45778 and mre 269
Article | Year |
---|---|
Anodal iontophoresis of a soluble guanylate cyclase stimulator induces a sustained increase in skin blood flow in rats.
Topics: Acetates; Acrylamides; Animals; Data Interpretation, Statistical; Electric Stimulation; Electrodes; Guanylate Cyclase; In Vitro Techniques; Iontophoresis; Male; Nitrosamines; Oxazoles; Platelet Aggregation Inhibitors; Pyrazines; Pyrazoles; Rats; Rats, Wistar; Receptors, Epoprostenol; Regional Blood Flow; Skin | 2013 |